Drug maker Lupin has received final approval from the US health regulator to market a generic version of UCB’s Keppra Oral Solution, an anti-epilepsy drug, in the American market.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/lupin-gets-final-usfda-nod-market-anti-epilepsy-drug
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/business-line-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/united-states-america-us
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/preventive-medicine
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs